← Leaderboards
Gordon J Leitch
Morehouse School Of Medicine
$1,168,124
Attributed
$1,168,124
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$1,168,124 · 3
By mechanism
G12$742,184 · 2
R21$425,940 · 1
Top collaborators
No co-investigators on record.
Most similar at Morehouse School Of Medicine
Same institution · by research overlap
- Jonathan K. Stiles$6,642,551
- Adel Driss$677,495
- Byron D. Ford$8,280,047
- Nerimiah L Emmett$3,896,126
Others in their field
Top investigators on “Infection”
- Wafaa M. El-Sadr · Columbia University Health Sciences$965,939,185
- Lawrence Corey · Fred Hutchinson Cancer Center$789,608,171
- Judith S. Currier · University Of California Los Angeles$511,038,212
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$463,711,983
- Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$415,229,497
Research focus
InfectionAnimal TissueParasitismImmunologyMinority Institution Research SupportInflammationGenomeVirusBacteriaBioimaging /Biomedical ImagingDisease /Disorder ModelDrug /AgentGeneticsLymphatic SystemMammaliaMicroscopyMineralsModel Design /DevelopmentMycosisOral PharyngealScanning Electron MicroscopyTechnology /TechniqueTissue /Cell CultureAids
Grant awards (9)
Polarized Intestinal Epithelial Microsporidiosis Model.$137,183
R21 · FY2005 · DK
Polarized Intestinal Epithelial Microsporidiosis Model.$79,117
R21 · FY2005 · DK
Polarized Intestinal Epithelial Microsporidiosis Model$209,640
R21 · FY2004 · DK
DEVELOP &ASSESS NOVEL TREATMENT FOR CRYPTOSPORIDIUM: AIDS: ANTIPARASITIC$110,670
G12 · FY2002 · RR
DEVELOP &ASSESS NOVEL TREATMENT FOR CRYPTOSPORIDIUM: AIDS: ANTIPARASITIC$110,670
G12 · FY2002 · RR
CHAR OF MICROBIAL HOST CELL INTERACTIONS: GINGIVALIS: MICROSPORIDIUM$110,670
G12 · FY2002 · RR
CHAR OF MICROBIAL HOST CELL INTERACTIONS: GINGIVALIS: MICROSPORIDIUM$110,670
G12 · FY2002 · RR
CHAR OF MICROBIAL HOST CELL INTERACTIONS: GINGIVALIS: MICROSPORIDIUM$149,752
G12 · FY2000 · RR
DEVELOP &ASSESS NOVEL TREATMENT FOR CRYPTOSPORIDIUM: AIDS: ANTIPARASITIC$149,752
G12 · FY2000 · RR